News

A solid start to the year First quarter summary - Revenue increased 3.5% to SEK 20,035 million (19,360) and like for like, revenue increased 3.3%. - Service ...
Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced the appointment of Renée Aguiar-Lucander as Chief Executive Officer (CEO), effective immediately. Søren ...